These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38384016)

  • 1. Prevalence and factors associated with oral potentially malignant disorders and oral squamous cell carcinoma: An institutional study.
    Shah JS; Dubey J
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S536-S544. PubMed ID: 38384016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
    Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
    Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on management of oral potentially malignant disorders.
    Birur PN; Patrick S; Warnakulasuriya S; Gurushanth K; Raghavan SA; Rath GK; Chaturvedi P; Chandru V; Mathew B; Prabhash K; Gurudath S; Mukhia N; Sunny SP; Mehrotra R; Vivek V; Patil S; Kumar GS; Fasalkar S; Pratima R; Kuriakose MA
    Indian J Cancer; 2022; 59(3):442-453. PubMed ID: 36412324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
    Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
    Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the levels of salivary paxillin in oral potentially malignant disorders and malignant lesions.
    Hussine AA; Selim K; Shaker O; Kamal Y
    BMC Oral Health; 2024 Jul; 24(1):834. PubMed ID: 39048985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
    Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypovitaminosis D, oral potentially malignant disorders, and oral squamous cell carcinoma: a systematic review.
    Maturana-Ramírez A; Aitken-Saavedra J; Guevara-Benítez AL; Espinoza-Santander I
    Med Oral Patol Oral Cir Bucal; 2022 Mar; 27(2):e135-e141. PubMed ID: 35218642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
    Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
    Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICI-based therapies: A new strategy for oral potentially malignant disorders.
    Wang T; Sun S; Zeng X; Li J
    Oral Oncol; 2023 May; 140():106388. PubMed ID: 37054586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs.
    Castagnola P; Gandolfo S; Malacarne D; Aiello C; Marino R; Zoppoli G; Ballestrero A; Giaretti W; Pentenero M
    PLoS One; 2017; 12(9):e0184425. PubMed ID: 28877236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
    McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
    Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
    Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
    J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features and risk factors associated with oral squamous cell carcinoma (OSCC): A comprehensive descriptive study analyzing the burden of OSCC in a tertiary-level hospital in North Kerala, India.
    Thankappan S; Nedumpillil S; Thomas V
    Indian J Cancer; 2023 Oct; 60(4):534-541. PubMed ID: 38195487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between dental implants and oral squamous cell carcinoma.
    Afrashtehfar KI; Almomani MM; Momani M
    Evid Based Dent; 2022 Mar; 23(1):40-42. PubMed ID: 35338331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma.
    Kouketsu A; Haruka S; Kuroda K; Hitoshi M; Kensuke Y; Tsuyoshi S; Takahashi T; Hiroyuki K
    J Oral Pathol Med; 2023 Jan; 52(1):9-19. PubMed ID: 36380437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smokeless tobacco use and oral potentially malignant disorders among people living with HIV (PLHIV) in Pune, India: Implications for oral cancer screening in PLHIV.
    Marbaniang I; Joshi S; Sangle S; Khaire S; Thakur R; Chavan A; Gupte N; Kulkarni V; Deshpande P; Nimkar S; Mave V
    PLoS One; 2022; 17(7):e0270876. PubMed ID: 35788753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hospital based prevalence of oral cancer among population of Kanpur, Uttar Pradesh.
    Raj A; Ramesh G; Pathak S
    J Exp Ther Oncol; 2018 May; 12(3):193-199. PubMed ID: 29790309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid droplets' functional protein caveolin-2 is associated with lipid metabolism-related molecule FABP5 and EMT marker E-cadherin in oral epithelial dysplasia.
    Chen XJ; Bai YT; Xie JR; Zhou G
    J Clin Pathol; 2024 Apr; 77(5):330-337. PubMed ID: 36854623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.